Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
News|Articles|November 23, 2009

Pharma Unplugged: FDA Social Media Hearing

A Link Apart : FDA Social Media Hearing


Pharma Unplugged Podcast Series



Download Adobe Flash Player


Sponsors

Patient Segmentation Strategies

WEBCAST – Sponsor (Medpoint)

How Virtual Media Can Save the Medical Speaker Program

WEBCAST – Sponsor (Healthgrades)

Driving Medication Compliance

PODCAST – Sponsor (AdherenceRx)


Topic:

(Nov 23, 2009) Think you’ve heard enough about the FDA Social Media Hearing held earlier this month. Granted, the gaggle of general and industry coverage was way more than one person can digest. So we asked four experts who spoke at the hearings to sit down with us and debate the issues. With so much at stake and so little clarity, we hope this hour long panel interview will help you figure out what it all means to you and your business.

Host:

George Koroneos, Online/News Editor: Pharmaceutical Executive

Panel:

Fabio Gratton, founder, Ignite Health

Fard Johnmar, founder, Envision Solutions

Bruce Grant, SVP, Business Strategy, Digitas Health

Bill Drummy, founder and CEO, Heartbeat Digital



Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.